The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Express Scripts Inc

  • Contact Person: Brian Duenwald
  • Contact Phone: 314-684-7891
  • Contact Email: bduenwald@express-scripts.com
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • For Profit Organization
  • Industries Served: Pharmacies and Drug Stores, Claims Adjusting, Third Party Administration of Insurance and Pension Funds, Administrative Management and General Management Consulting Services, Offices of All Other Miscellaneous Health Practitioners
  • Product Areas: MEDICAL- PHARMACOLOGY, PHARMACOLOGY SERVICES

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $882,261 - Friday the 21st of October 2011
    Tricare Management Activity
    DEFENSE HEALTH AGENCY AURORA
    THE PURPOSE OF THIS MODIFICATION (P00209) IS TO PROVIDE ADDITIONAL FUNDING NEEDED TO SUPPORT PHARMACY OPERATIONS FOR SEPTEMBER, 2011.
  • $86,204 - Thursday the 13th of September 2012
    Tricare Management Activity
    DEFENSE HEALTH AGENCY AURORA
    THE PURPOSE OF THIS MODIFICATION (P00271) IS TO INCORPORATE TOM82, TRM71, TPM75, AND TSM41 DATED AUGUST 24, 2012, INTO THE CONTRACT TO CONVERT FROM INTERNATIONAL CLASSIFICATIONS OF DISEASES 9TH REVISION (ICD-09) TO INTERNATIONAL CLASSIFICATION OF DISEASES, 10TH REVISION (ICD-10).
  • $7,928,885 - Tuesday the 25th of October 2011
    Tricare Management Activity
    DEFENSE HEALTH AGENCY AURORA
    THE PURPOSE OF THIS MODIFICATION (P00214) IS TO OBLIGATE ADDITIONAL (FY12) FUNDS NEEDED TO SUPPORT PHARMACY OPERATIONS DURING OCTOBER, 2011.
  • $71,667 - Monday the 14th of May 2012
    Tricare Management Activity
    DEFENSE HEALTH AGENCY AURORA
    THE PURPOSE OF THIS MODIFICATION (P00250) IS TO ENHANCE PATIENT SAFETY DURING THE IMPLEMENTATION OF DOD PHARMACY&THERAPEUTIC (P&T) COMMITTEE DECISIONS; BY WHICH BENEFICIARIES ARE SHIFTED TO A PREFERRED PHARMACEUTICAL PRODUCT. WHEN A PRESCRIPTION IS DENIED DUE TO P&T STEP THERAPY GUIDANCE, THE CONTRACTOR WILL CONTACT THE BENEFICIARY AND THE PRESCRIBING PROVIDER, TO IDENTIFY ALTERNATIVES FOR THE DRUG IN QUESTION; THUS MINIMIZING GAPS OR A DELAY IN BENEFICIARY TREATMENT.
  • $53,972,468 - Tuesday the 17th of July 2012
    Tricare Management Activity
    DEFENSE HEALTH AGENCY AURORA
    THE PURPOSE OF THIS MODIFICATION (P00266) IS TO PROVIDE ADDITIONAL FY12 FUNDING NEEDED TO SUPPORT PHARMACY OPERATIONS DURING OP3.
  • $511,124 - Wednesday the 7th of December 2011
    Tricare Management Activity
    DEFENSE HEALTH AGENCY AURORA
    THE PURPOSE OF THIS MODIFICATION (P00221) IS TO PROVIDE ADDITIONAL FY12 FUNDING NEEDED TO SUPPORT PHARMACY OPERATIONS FOR OCTOBER, 2011.
  • $46,256,053 - Friday the 10th of July 2015
    Tricare Management Activity
    DEFENSE HEALTH AGENCY AURORA
    IN ACCORDANCE WITH FAR CLAUSE 52.217-9, OPTION TO EXTEND THE TERM OF THE CONTRACT THE GOVERNMENT HEREBY UNILATERALLY EXERCISES ITS OPTION TO EXTEND THE TERM OF CONTRACT H94002-08-C-0008 FOR OPTION PERIOD 3 (OP3); WITH A PERIOD OF PERFORMANCE OF NOVEMBER 1, 2011 THROUGH OCT 31, 2012.
  • $4,293 - Tuesday the 13th of March 2012
    Veterans Affairs Department
    618-MINNEAPOLIS VA MEDICAL CENTER
    DRUGS AND BIOLOGICALS FOR PHARMACY.
  • $4,293 - Friday the 10th of February 2012
    Veterans Affairs Department
    618-MINNEAPOLIS VA MEDICAL CENTER
    RX 9805036A-5 BOSENTAN 62.5MG TAB
  • $4,292 - Monday the 5th of March 2012
    Veterans Affairs Department
    618-MINNEAPOLIS VA MEDICAL CENTER
    BOSENTAN 125/MG 60 TABS PER BOTTLE

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.